Effective natural interferon-alpha therapy recombinant interferon-alpha-resistant patients hairy cell leukemia relationship anti-interferon-alpha anti-IFN-alpha antibodies loss clinical responsiveness IFN-alpha treatment sera patients hairy cell leukemia recombinant first years therapy patients antibodies Nine patients resistant relapse disease months treatment patients positive neutralizing antibodies titers INU/mL none antibody-negative patients patients detectable antibody titers INU/mL treatment IFN kinetics levels IFN-induced Mx-homologous protein mononuclear cells single injection nIFN-alpha IFN antibodies resistant rIFN-alpha patients specific patients natural IFN-alpha nIFN-alpha therapy doses IU times week patients treatment nIFN-alpha durable objective responses similar data rIFN-alpha antibody-positive patients nIFN-alpha 